BIO-key International, Inc.
BKYI
$0.77
$0.0010.13%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.46M | 2.14M | 1.14M | 2.18M | 1.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.46M | 2.14M | 1.14M | 2.18M | 1.83M |
| Cost of Revenue | 262.40K | 465.10K | 262.30K | 299.60K | 1.92M |
| Gross Profit | 1.20M | 1.68M | 879.00K | 1.88M | -95.50K |
| SG&A Expenses | 1.85M | 1.61M | 1.94M | 1.78M | 2.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.73M | 2.73M | 2.80M | 2.69M | 4.55M |
| Operating Income | -1.27M | -580.40K | -1.65M | -508.90K | -2.72M |
| Income Before Tax | -1.41M | -739.00K | -1.67M | -510.30K | -2.65M |
| Income Tax Expenses | -23.00K | -- | -- | -- | -276.80K |
| Earnings from Continuing Operations | -1.38M | -739.00K | -1.67M | -510.30K | -2.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.38M | -739.00K | -1.67M | -510.30K | -2.37M |
| EBIT | -1.27M | -580.40K | -1.65M | -508.90K | -2.72M |
| EBITDA | -1.17M | -480.00K | -1.55M | -407.10K | -2.55M |
| EPS Basic | -0.46 | -0.39 | -1.00 | -0.32 | -4.46 |
| Normalized Basic EPS | -0.29 | -0.24 | -0.63 | -0.20 | -3.29 |
| EPS Diluted | -0.46 | -0.39 | -1.00 | -0.32 | -4.46 |
| Normalized Diluted EPS | -0.29 | -0.24 | -0.63 | -0.20 | -3.29 |
| Average Basic Shares Outstanding | 3.03M | 1.89M | 1.66M | 1.62M | 531.50K |
| Average Diluted Shares Outstanding | 3.03M | 1.89M | 1.66M | 1.62M | 531.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |